47 Past, present, and future of red blood cells REFERENCES 1. Zarychanski R, Ariano RE, Paunovic B, et al. Historical perspectives in critical care medicine: blood transfusion, intravenous fluids, inotropes/vasopressors, and antibiotics. Crit Care Clin 2009;25:201-20 x. 2. Amrolia PJ, Almeida A, Halsey C, et al. Therapeutic challenges in childhood sickle cell disease. Part 1: current and future treatment options. Br J Haematol 2003;120:725-36. 3. Alter HJ, Klein HG. The hazards of blood transfusion in historical perspective. Blood 2008;112:2617-26. 4. McCullough J. Innovation in transfusion medicine and blood banking: documenting the record in 50 years of TRANSFUSION Transfusion 2010;50:2542-6. 5. Ellingson KD, Sapiano MRP, Haass KA, et al. Continued decline in blood collection and transfusion in the United States-2015. Transfusion 2017;57(Suppl 2):1588-98. 6. Chung KW, Basavaraju SV, Mu Y, et al. Declining blood collection and utilization in the United States. Transfusion 2016;56:2184-92. 7. Shander AIJ, Gombotz H. Patient blood management: the global view. Transfusion 2016;56(Suppl 1):S94-102. 8. Harrison BT, Chen J, Der Vartanian C, et al. Improving red cell transfusion in the elective surgical setting: an improvement collaborative with evaluation. Vox Sang 2015;108:393-402. 9. Network APB. Comparison of practice (CoP) measures. 2019. 10. Tinegate H, Chattree S, Iqbal A, et al. Ten-year pattern of red blood cell use in the North of England. Transfusion 2013;53:483-9. 11. Schonborn L, Weitmann K, Greger N, et al. Longitudinal changes in the blood supply and demand in north-east- Germany 2005-2015. Transfus Med Hemother 2017;44:224-31. 12. Janssen MP, van Hoeven LR, Rautmann G. Trends and obser- vations on the collection, testing and use of blood and blood components in Europe. A 2001-2011 Report. Strasbourg, France: European Directorate for the Quality of Medicines & Health Care of the Council of Europe (EDQM); 2015. 13. Volken T, Buser A, Castelli D, et al. Red blood cell use in Switzerland trends and demographic challenges. Blood Transfus 2018;16:73-82. 14. van Hoeven L, Koopman R, Koffijberg H, et al. Historical time trends in red blood cell usage in The Netherlands. Int J Clin Transfus Med 2016;4:67-77. 15. Seifried E, Klueter H, Weidmann C, et al. How much blood is needed? Vox Sang 2011;100:10-21. 16. Currie CJ, Patel TC, McEwanz P, et al. Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service. Transfus Med 2004;14:19-24.
RkJQdWJsaXNoZXIy MTk4NDMw